Author:
Sahu Ram Kumar,Yadav Rajni,Prasad Pushpa,Roy Amit,Chandrakar Shashikant
Publisher
Springer Science and Business Media LLC
Reference91 articles.
1. Aeries N: Consumer reporting of ADRs. WHO Drug Information 1995, 14: 211-215.
2. Arnott J, Hesselgreaves H, Nunn AJ, Peak M, Pirmohamed M: What can we learn from parents about enhancing participation in Pharmacovigilance? British J Clin Pharmacol 2012, 78(2):312-322.
3. Arora D: Pharmacovigilance obligations of the pharmaceutical companies in India. Indian J Pharmacol 2008, 40: 13-16.
4. Bahri P, Tsintis P: Pharmacovigilance–related topics at the level of the International Conference on Harmonisation (ICH). Pharmacoepidemiol Drug Saf 2005, 14: 377-387. 10.1002/pds.1043
5. Bates DW, Cullen DJ, Laird N: Incidence of adverse drug events and potential adverse drug events. JAMA 1995, 274: 29-34. 10.1001/jama.1995.03530010043033
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献